{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:41:49Z","timestamp":1790264509213,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-INBS-0011"],"award-info":[{"award-number":["ANR-11-INBS-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE15-0007-01"],"award-info":[{"award-number":["ANR-14-CE15-0007-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bbrc.2016.09.065","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T21:50:00Z","timestamp":1473976200000},"page":"1084-1095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Energy defects in Huntington's disease: Why \u201cin\u00a0vivo\u201d evidence matters"],"prefix":"10.1016","volume":"483","author":[{"given":"G\u00e9raldine","family":"Liot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Flament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7403","authenticated-orcid":false,"given":"Emmanuel","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.09.065_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.09.065_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.09.065_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(03)00116-8","article-title":"Mitochondria: releasing power for life and unleashing the machineries of death","volume":"112","author":"Newmeyer","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.09.065_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib7","series-title":"Huntington's Disease","author":"Harper","year":"1991"},{"key":"10.1016\/j.bbrc.2016.09.065_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib10","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbrc.2016.09.065_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","article-title":"Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat","volume":"39","author":"Ruocco","year":"2006","journal-title":"Braz J. Med. Biol. Res."},{"key":"10.1016\/j.bbrc.2016.09.065_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2016.09.065_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.09.065_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington's disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/mds.26008","article-title":"Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease","volume":"29","author":"Howland","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.065_bib19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington's disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.065_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib21","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbrc.2016.09.065_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7854_2013_256","article-title":"Mouse models of Huntington's disease","volume":"22","author":"Brooks","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib26","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1385\/MN:28:3:259","article-title":"Wild-type huntingtin plays a role in brain development and neuronal survival","volume":"28","author":"Reiner","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.09.065_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib31","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib32","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib33","doi-asserted-by":"crossref","first-page":"39594","DOI":"10.1074\/jbc.C200353200","article-title":"Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons","volume":"277","author":"Goffredo","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib34","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","article-title":"Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.09.065_bib35","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mad.2006.01.022","article-title":"Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease","volume":"127","author":"Lee","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2016.09.065_bib38","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease","volume":"285","author":"Landles","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib40","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2016.09.065_bib41","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.15252\/embj.201490808","article-title":"Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation","volume":"34","author":"El-Daher","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2016.09.065_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN translation in Huntington disease","volume":"88","author":"Banez-Coronel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.09.065_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","article-title":"What have we learned from gene expression profiles in Huntington's disease?","volume":"45","author":"Seredenina","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00295","article-title":"Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease","volume":"8","author":"Francelle","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib49","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","article-title":"Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites","volume":"33","author":"Liot","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1100\/tsw.2008.60","article-title":"The ubiquitin-proteasome pathway in Huntington's disease","volume":"8","author":"Finkbeiner","year":"2008","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bbrc.2016.09.065_bib51","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-007-7222-8","article-title":"Is the ubiquitin-proteasome system impaired in Huntington's disease?","volume":"64","author":"Ortega","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4161\/auto.2696","article-title":"Protective roles for induction of autophagy in multiple proteinopathies","volume":"2","author":"Menzies","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2016.09.065_bib53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib54","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1517\/13543784.16.12.1933","article-title":"Huntington's disease: progress and potential in the field","volume":"16","author":"Stack","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbrc.2016.09.065_bib55","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.09.065_bib56","article-title":"Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases - role of ER-mitochondria crosstalk","author":"Naia","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.09.065_bib57","article-title":"Striatal synaptic dysfunction and altered calcium regulation in Huntington disease","author":"Raymond","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.09.065_bib58","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","article-title":"Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells","volume":"21","author":"Feyeux","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2016.09.065_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","article-title":"Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum","volume":"114","author":"Oliveira","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.25835","article-title":"Prospects for neuroprotective therapies in prodromal Huntington's disease","volume":"29","author":"Chandra","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.065_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2015.09.008","article-title":"Mitochondrial dynamics and quality control in Huntington's disease","volume":"90","author":"Guedes-Dias","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib66","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2016.09.065_bib67","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","article-title":"Mutant huntingtin and elusive defects in oxidative metabolism and mitochondrial calcium handling","volume":"53","author":"Brustovetsky","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib68","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib69","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00585-4","article-title":"In\u00a0vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease","volume":"410","author":"Panov","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2016.09.065_bib71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib72","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajhg.2008.03.020","article-title":"Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ","volume":"82","author":"Barel","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1095-144","article-title":"Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency","volume":"11","author":"Bourgeron","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib74","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.378","article-title":"SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy","volume":"41","author":"Ghezzi","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib75","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/hmg\/ddn441","article-title":"Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence","volume":"18","author":"Ghezzi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib76","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/WNL.45.12.2178","article-title":"Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)","volume":"45","author":"He","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib77","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib78","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib80","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.09.065_bib81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib82","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib83","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib84","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib85","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib86","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib89","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2016.09.065_bib90","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib91","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib93","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib95","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/exnr.2000.7626","article-title":"Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production","volume":"169","author":"Guidetti","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib96","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/hmg\/ddm057","article-title":"Hsp27 overexpression in the R6\/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation","volume":"16","author":"Zourlidou","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib97","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.bbrc.2016.09.065_bib98","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A\u00a0large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.bbrc.2016.09.065_bib99","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","article-title":"A\u00a0role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin","volume":"22","author":"Damiano","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In\u00a0vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib101","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","article-title":"Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II","volume":"17","author":"Benchoua","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib102","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10571-007-9220-7","article-title":"Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range","volume":"27","author":"Majumder","year":"2007","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib103","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/hmg\/ddl248","article-title":"Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III","volume":"15","author":"Solans","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw133","article-title":"Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington's disease","author":"Hamilton","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib105","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib106","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/hmg\/ddv209","article-title":"Oxidative metabolism in YAC128 mouse model of Huntington's disease","volume":"24","author":"Hamilton","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib107","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","article-title":"Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts","volume":"51","author":"Naia","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.npep.2016.01.009","article-title":"Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin","volume":"58","author":"Naia","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbrc.2016.09.065_bib109","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib110","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib111","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2012.09.002","article-title":"hMTH1 expression protects mitochondria from Huntington's disease-like impairment","volume":"49","author":"Ventura","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib112","doi-asserted-by":"crossref","first-page":"12646","DOI":"10.1038\/ncomms12646","article-title":"VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease","volume":"7","author":"Guo","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2016.09.065_bib113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-8-45","article-title":"Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease","volume":"8","author":"Quintanilla","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2016.09.065_bib114","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","article-title":"Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway","volume":"13","author":"Ruan","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"issue":"Suppl","key":"10.1016\/j.bbrc.2016.09.065_bib118","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10","author":"Bossy-Wetzel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib119","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib121","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1074\/jbc.M112.407726","article-title":"Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease","volume":"288","author":"Wang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib122","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib123","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib124","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib126","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","article-title":"Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway","volume":"16","author":"Liot","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2016.09.065_bib127","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ars.2012.4928","article-title":"S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease","volume":"19","author":"Haun","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bbrc.2016.09.065_bib128","doi-asserted-by":"crossref","first-page":"e57932","DOI":"10.1371\/journal.pone.0057932","article-title":"Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.09.065_bib129","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib130","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2016.09.065_bib131","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.bbadis.2015.06.025","article-title":"Cdk5-mediated mitochondrial fission: a key player in dopaminergic toxicity in Huntington's disease","volume":"1852","author":"Cherubini","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2016.09.065_bib132","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib133","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib134","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.09.065_bib135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcb.20743","article-title":"Nuclear control of respiratory gene expression in mammalian cells","volume":"97","author":"Scarpulla","year":"2006","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib136","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2016.09.065_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.4003","article-title":"PPAR-delta is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically","volume":"22","author":"Dickey","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib138","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington's disease","volume":"125","author":"Jin","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib139","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib140","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw095","article-title":"Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease","author":"Chandra","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib141","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib142","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.09.065_bib143","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-014-0006-5","article-title":"Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease","volume":"70","author":"Kamat","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2016.09.065_bib144","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib145","doi-asserted-by":"crossref","first-page":"e1617","DOI":"10.1038\/cddis.2014.581","article-title":"PINK1-induced mitophagy promotes neuroprotection in Huntington's disease","volume":"6","author":"Khalil","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib146","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","article-title":"The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation","volume":"34","author":"Wong","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib147","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.15252\/emmm.201505256","article-title":"Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease","volume":"7","author":"Hwang","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib148","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.09.065_bib149","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.05-5085fje","article-title":"Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation","volume":"20","author":"Jacquard","year":"2006","journal-title":"Faseb J."},{"key":"10.1016\/j.bbrc.2016.09.065_bib150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/exnr.1993.1071","article-title":"Mitochondrial impairment reduces the threshold for in\u00a0vivo NMDA-mediated neuronal death in the striatum","volume":"121","author":"Simpson","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib151","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","article-title":"Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease","volume":"45","author":"Bezprozvanny","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib152","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bbrc.2016.09.065_bib153","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in\u00a0vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib154","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib156","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/nbdi.1999.0244","article-title":"Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid","volume":"6","author":"Dautry","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib157","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00004647-200005000-00005","article-title":"Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid","volume":"20","author":"Dautry","year":"2000","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbrc.2016.09.065_bib158","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1471-4159.2002.01006.x","article-title":"Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in\u00a0vivo 1H-[13C] NMR spectroscopy","volume":"82","author":"Henry","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib159","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004647-199605000-00011","article-title":"Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging","volume":"16","author":"Jenkins","year":"1996","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbrc.2016.09.065_bib160","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"75","author":"Sturrock","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib161","first-page":"2230","article-title":"Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in\u00a0vivo evidence for impaired energy metabolism","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib162","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JHD-140117","article-title":"Longitudinal metabolite changes in Huntington's disease during disease onset","volume":"3","author":"van den Bogaard","year":"2014","journal-title":"J.\u00a0Huntingt. Dis."},{"key":"10.1016\/j.bbrc.2016.09.065_bib163","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","article-title":"Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease","volume":"32","author":"Tkac","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbrc.2016.09.065_bib164","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1046\/j.1471-4159.2000.0742108.x","article-title":"Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice","volume":"74","author":"Jenkins","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroimage.2016.06.023","article-title":"In\u00a0vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease","volume":"139","author":"Pepin","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbrc.2016.09.065_bib166","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","article-title":"Neurochemical changes in Huntington R6\/2 mouse striatum detected by in\u00a0vivo 1H NMR spectroscopy","volume":"100","author":"Tkac","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib167","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","article-title":"Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease","volume":"95","author":"Jenkins","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.09.065_bib168","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.09.065_bib169","doi-asserted-by":"crossref","first-page":"e0148839","DOI":"10.1371\/journal.pone.0148839","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of Huntington's disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.09.065_bib170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/nbm.1940020505","article-title":"Brain metabolites as 1H NMR markers of neuronal and glial disorders","volume":"2","author":"Gill","year":"1989","journal-title":"NMR Biomed."},{"key":"10.1016\/j.bbrc.2016.09.065_bib171","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mrm.1910300506","article-title":"Metabolic assessment of a neuron-enriched fraction of rat cerebrum using high-resolution 1H and 13C NMR spectroscopy","volume":"30","author":"Petroff","year":"1993","journal-title":"Magn. Reson Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib172","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0306-4522(91)90101-S","article-title":"Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies","volume":"45","author":"Simmons","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.09.065_bib173","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington's disease","volume":"32","author":"Zacharoff","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbrc.2016.09.065_bib174","first-page":"164","article-title":"NMR imaging of labile proton exchange","volume":"86","author":"Wolff","year":"1990","journal-title":"J.\u00a0Magnetic Reson."},{"key":"10.1016\/j.bbrc.2016.09.065_bib175","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nm.2615","article-title":"Magnetic resonance imaging of glutamate","volume":"18","author":"Cai","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib176","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/jcbfm.2015.48","article-title":"The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in\u00a0vivo multimodal magnetic resonance imaging study","volume":"35","author":"Carrillo-de Sauvage","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbrc.2016.09.065_bib177","doi-asserted-by":"crossref","first-page":"309ra161","DOI":"10.1126\/scitranslmed.aaa7095","article-title":"Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy","volume":"7","author":"Davis","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2016.09.065_bib178","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.50.4.1033","article-title":"Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases","volume":"50","author":"Hoang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib179","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in\u00a0vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib180","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.065_bib181","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.25009","article-title":"Abnormal response to cortical activation in early stages of Huntington disease","volume":"27","author":"Mochel","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.09.065_bib182","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.0000000000001214","article-title":"Triheptanoin improves brain energy metabolism in patients with Huntington disease","volume":"84","author":"Adanyeguh","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2016.09.065_bib183","series-title":"Remodeling of Energy Metabolism Revealed by 31P Magnetization Transfer in a Transgenic Rat Model of Huntington's Disease","author":"Tiret","year":"2016"},{"key":"10.1016\/j.bbrc.2016.09.065_bib184","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ejhg.2010.72","article-title":"Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease","volume":"18","author":"Mochel","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib185","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","article-title":"Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes","volume":"25","author":"Polyzos","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib186","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.09.065_bib187","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2016.09.065_bib188","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12035-014-8663-3","article-title":"Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime","volume":"50","author":"Eckmann","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.09.065_bib189","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli","volume":"2","author":"Costa","year":"2010","journal-title":"EMBO Mol. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1631525X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1631525X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:20:27Z","timestamp":1718796027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1631525X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":189,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0006291X1631525X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.065","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Energy defects in Huntington's disease: Why \u201cin\u00a0vivo\u201d evidence matters","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}